RENAMIN W/O ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Renamin W/o Electrolytes, and when can generic versions of Renamin W/o Electrolytes launch?
Renamin W/o Electrolytes is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in RENAMIN W/O ELECTROLYTES is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Renamin W/o Electrolytes
A generic version of RENAMIN W/O ELECTROLYTES was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for RENAMIN W/O ELECTROLYTES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RENAMIN W/O ELECTROLYTES at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for RENAMIN W/O ELECTROLYTES
US Patents and Regulatory Information for RENAMIN W/O ELECTROLYTES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | RENAMIN W/O ELECTROLYTES | amino acids | INJECTABLE;INJECTION | 017493-007 | Oct 15, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |